Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma

Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)

Yen‐Yu Lu, Xiaolin Zi, Yuqing Zhao et al. · JNCI Journal of the National Cancer Institute · 2001 · 889 citations · Full text

Medicine, Oncology, Pharmacology +15

Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line

Péter Nagy, Elza Friedländer, Minna Tanner et al. · Cancer Research · 2005 · 513 citations · Full text

Medicine, Cancer Biology, Molecular Biology +14

Tumor Characteristics and Clinical Outcome of Tubular and Mucinous Breast Carcinomas

Sami Diab, Gary M. Clark, C. Kent Osborne et al. · Journal of Clinical Oncology · 1999 · 303 citations

Medicine, Oncology, Pathology +16

Rat Muc4 (sialomucin complex) reduces binding of anti‐ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance

Shari A. Price‐Schiavi, Scott Jepson, Peter Li et al. · International Journal of Cancer · 2002 · 210 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

The Role of Cyclin-dependent Kinase Inhibitor p27Kip1 in Anti-HER2 Antibody-induced G1 Cell Cycle Arrest and Tumor Growth Inhibition

Xiao-Feng Le, François-Xavier Claret, Amy Lammayot et al. · Journal of Biological Chemistry · 2003 · 148 citations · Full text

Life Sciences, Cancer Biology, Oncology +17